Since the beginning of the pandemic, more than one million people hospitalised with COVID-19 have been treated with Actemra worldwide Basel, 21 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today ...
When Sanofi and Regeneron’s Kevzara and Roche’s Actemra both flopped in trials in COVID-19 patients, it looked like the end of road for targeting IL-6 to control coronavirus-related pneumonia. But now ...
As one of the earliest drugs proposed to treat COVID-19, Roche’s arthritis therapy Actemra has already amassed a large pool of data for that use—but it’s a muddy one. And now, the IL-6 inhibitor has ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company is working with the U.S. Food & Drug Administration ...
– EMPACTA is the first global Phase III trial to show efficacy with Actemra in COVID-19 associated pneumonia and the first with a focus on enrolling largely underserved and minority patients – “The ...
Swiss drug maker Roche will mix Remdesivir with Actemra to see the efficacy in treating Covid-19 Roche is hoping that by combining the two in a global study of 450 hospitalised patients worldwide, it ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III EMPACTA study met its primary endpoint, showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results